Skip to main content

Table 3 Incidence of adverse events

From: Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-Blind, randomized, placebo-controlled study

Variable

Total (n = 304)

Statin + CoA (n = 152)

Statin + Placebo (n = 152)

Any AE

25

14

11

Serous AEs

1

0

1

Patients who experienced any AE

23

12

11

Lead to treatment discontinuation

4

0

4

Most common AEs

   

  Abdominal distention

1

1

0

  Nausea

2

1

1

  Chest pain

1

0

1

  Elevated liver enzymes

1

1

0

  Elevated creatine phosphokinase

7

3

4

  Upper respiratory tract infection

5

4

1

  1. Note: CoA = coenzyme A; AE = adverse event.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X